NL
DE
.aspx?width=300&height=190&ext=.jpg&type=BlockColumn1Zoom1)
Myotonic Dystrophy is an autosomal dominantly inherited multisystem disorder (MD type 1 and MD type 2). The main objective of forming a disease-oriented biobank is the structured storage of biomaterial and clinical data, both for research purposes within the Radboudumc and for (inter)national collaborations in the future. For both MD1 and MD2, investigation of DNA and pathophysiological mechanisms will be an important objective, with identification of targets for therapy.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
First implications of the Radboud Biobank new business model
15 July 2025It was communicated in an earlier news item that the Radboudumc Board of Directors decided to change the Radboud Biobank business model.
go to page
Relocation of Radboud Biobank samples to Central Freezing Facility
15 July 2025The Radboud Biobank has now transferred almost all stored samples to the central freezing facility.
go to page
Standardized Radboud Biobank procedures for sample handling in Elabgids
15 July 2025The Radboud Biobank is currently preparing to include all standardized Radboud Biobank procedures for sample handling in the eLabgids.
go to page
Temporary new location Radboud Biobank Office
15 July 2025The Radboud Biobank office has moved to a temporary new location: route 832 - M325.04.255 (building F).
go to page
Europe Biobank Week 2025
15 July 2025The Europe Biobank Week 2025 was a great success for the Dutch biobank community with a strong presence of Dutch biobanking and biomedical research.
go to page
National Biobanks & Collections Dag 2025
6 May 2025The second edition of the National Biobanks & Collections Day took place on March 27, 2025, in Nijmegen and attracted 150 participants from all over the Netherlands.
go to page